BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 26071379)

  • 1. A neutrophil inhibitory pepducin derived from FPR1 expected to target FPR1 signaling hijacks the closely related FPR2 instead.
    Winther M; Gabl M; Welin A; Dahlgren C; Forsman H
    FEBS Lett; 2015 Jul; 589(15):1832-9. PubMed ID: 26071379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The leukocyte chemotactic receptor FPR2, but not the closely related FPR1, is sensitive to cell-penetrating pepducins with amino acid sequences descending from the third intracellular receptor loop.
    Forsman H; Bylund J; Oprea TI; Karlsson A; Boulay F; Rabiet MJ; Dahlgren C
    Biochim Biophys Acta; 2013 Aug; 1833(8):1914-23. PubMed ID: 23562731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formyl peptide derived lipopeptides disclose differences between the receptors in mouse and men and call the pepducin concept in question.
    Winther M; Holdfeldt A; Sundqvist M; Rajabkhani Z; Gabl M; Bylund J; Dahlgren C; Forsman H
    PLoS One; 2017; 12(9):e0185132. PubMed ID: 28934373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pepducin designed to modulate P2Y2R function interacts with FPR2 in human neutrophils and transfers ATP to an NADPH-oxidase-activating ligand through a receptor cross-talk mechanism.
    Gabl M; Holdfeldt A; Winther M; Oprea T; Bylund J; Dahlgren C; Forsman H
    Biochim Biophys Acta; 2016 Jun; 1863(6 Pt A):1228-37. PubMed ID: 26996596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The PAR4-derived pepducin P4Pal
    Holdfeldt A; Lind S; Hesse C; Dahlgren C; Forsman H
    Biochem Pharmacol; 2020 Oct; 180():114143. PubMed ID: 32653592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pepducin derived from the third intracellular loop of FPR2 is a partial agonist for direct activation of this receptor in neutrophils but a full agonist for cross-talk triggered reactivation of FPR2.
    Gabl M; Winther M; Skovbakke SL; Bylund J; Dahlgren C; Forsman H
    PLoS One; 2014; 9(10):e109516. PubMed ID: 25303226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural characterization and inhibitory profile of formyl peptide receptor 2 selective peptides descending from a PIP2-binding domain of gelsolin.
    Forsman H; Andréasson E; Karlsson J; Boulay F; Rabiet MJ; Dahlgren C
    J Immunol; 2012 Jul; 189(2):629-37. PubMed ID: 22706076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A membrane-tethering pepducin that inhibits formyl peptide receptor 2-induced signaling.
    Lee HY; Kim H; Lee SY; Jung YS; Kim SD; Bae YS
    Pharmazie; 2014 Apr; 69(4):293-6. PubMed ID: 24791594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The proteolytically stable peptidomimetic Pam-(Lys-βNSpe)6-NH2 selectively inhibits human neutrophil activation via formyl peptide receptor 2.
    Skovbakke SL; Heegaard PM; Larsen CJ; Franzyk H; Forsman H; Dahlgren C
    Biochem Pharmacol; 2015 Jan; 93(2):182-95. PubMed ID: 25462815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FPR2 signaling without β-arrestin recruitment alters the functional repertoire of neutrophils.
    Gabl M; Holdfeldt A; Sundqvist M; Lomei J; Dahlgren C; Forsman H
    Biochem Pharmacol; 2017 Dec; 145():114-122. PubMed ID: 28855087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide length and folding state govern the capacity of staphylococcal β-type phenol-soluble modulins to activate human formyl-peptide receptors 1 or 2.
    Kretschmer D; Rautenberg M; Linke D; Peschel A
    J Leukoc Biol; 2015 Apr; 97(4):689-97. PubMed ID: 25724390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basic characteristics of the neutrophil receptors that recognize formylated peptides, a danger-associated molecular pattern generated by bacteria and mitochondria.
    Dahlgren C; Gabl M; Holdfeldt A; Winther M; Forsman H
    Biochem Pharmacol; 2016 Aug; 114():22-39. PubMed ID: 27131862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The FPR2-specific ligand MMK-1 activates the neutrophil NADPH-oxidase, but triggers no unique pathway for opening of plasma membrane calcium channels.
    Karlsson J; Stenfeldt AL; Rabiet MJ; Bylund J; Forsman HF; Dahlgren C
    Cell Calcium; 2009 May; 45(5):431-8. PubMed ID: 19282028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitocryptide-2: Identification of Its Minimum Structure for Specific Activation of FPR2-Possible Receptor Switching from FPR2 to FPR1 by Its Physiological C-terminal Cleavages.
    Marutani T; Nishino K; Miyaji T; Kamada K; Ohura K; Kiso Y; Mukai H
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A membrane-tethering pepducin derived from formyl peptide receptor 3 shows strong therapeutic effects against sepsis.
    Lee HY; Kim HS; Jeong YS; Kim JC; Bae YS; Jo YH; Park JS; Bae YS
    Biochem Biophys Res Commun; 2020 Mar; 524(1):156-162. PubMed ID: 31982133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural changes of the ligand and of the receptor alters the receptor preference for neutrophil activating peptides starting with a formylmethionyl group.
    Forsman H; Winther M; Gabl M; Skovbakke SL; Boulay F; Rabiet MJ; Dahlgren C
    Biochim Biophys Acta; 2015 Jan; 1853(1):192-200. PubMed ID: 25447672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stable formyl peptide receptor agonists that activate the neutrophil NADPH-oxidase identified through screening of a compound library.
    Forsman H; Kalderén C; Nordin A; Nordling E; Jensen AJ; Dahlgren C
    Biochem Pharmacol; 2011 Feb; 81(3):402-11. PubMed ID: 21095183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Honokiol suppresses formyl peptide-induced human neutrophil activation by blocking formyl peptide receptor 1.
    Liu FC; Yu HP; Syu YT; Fang JY; Lin CF; Chang SH; Lee YT; Hwang TL
    Sci Rep; 2017 Jul; 7(1):6718. PubMed ID: 28751674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of human monocytes by a formyl peptide receptor 2-derived pepducin.
    Lee HY; Kim SD; Shim JW; Kim HJ; Kwon JY; Kim JM; Baek SH; Park JS; Bae YS
    FEBS Lett; 2010 Sep; 584(18):4102-8. PubMed ID: 20804753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A non-peptide receptor inhibitor with selectivity for one of the neutrophil formyl peptide receptors, FPR 1.
    Cevik-Aras H; Kalderén C; Jenmalm Jensen A; Oprea T; Dahlgren C; Forsman H
    Biochem Pharmacol; 2012 Jun; 83(12):1655-62. PubMed ID: 22410002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.